Trump Expands Visa Health Denials
Analysis based on 7 articles · First reported Nov 07, 2025 · Last updated Nov 07, 2025
The new visa policy by Donald Trump's administration could impact the healthcare industry by potentially reducing the number of immigrants who might require medical services in the United States. It also creates uncertainty for individuals and businesses involved in immigration processes, potentially affecting the flow of skilled labor and family reunification.
The Donald Trump administration issued a directive through the United States — United States Department of State, expanding the criteria for denying U.S. visas to foreign nationals with certain medical conditions, including diabetes and obesity. This guidance instructs visa officers to consider an applicant's health and age as factors that could make them a 'public charge,' potentially relying on U.S. government resources for costly long-term care. The policy broadens traditional health screenings, which focused on communicable diseases, to include chronic illnesses like cardiovascular diseases, respiratory diseases, cancers, metabolic diseases, neurological diseases, and mental health conditions. Critics, including Charles Wheeler of the Catholic Legal Immigration Network and Sophia Genovese of Georgetown University, argue that the directive gives medically untrained visa officers excessive discretion and encourages speculation based on personal bias, potentially excluding millions worldwide with common chronic conditions. This move is part of Donald Trump's broader campaign to tighten immigration policies in the United States.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard